Authors noted it may be worthwhile to explore whether oral methylphenidate affects myopia by influencing dopamine levels ...

The FDA accepted Aldeyra's resubmitted NDA for reproxalap after previous rejections due to efficacy concerns, despite no ...

AAVB-039 advances gene therapy for Stargardt disease, aiming for innovative treatments for inherited retinal disorders.

KAIST developed a microbial strain for efficient lutein production, offering an eco-friendly alternative to traditional ...

Included in the agreement are ranibizumab-nuna 0.05 mL injection (BYOOVIZ), referencing LUCENTIS (ranibizumab), and ...

To mark Ophthalmology Times' 50th anniversary, we invited top experts to reflect on the most significant innovations in ...

The tool is designed to help with the application of mono-dose, dry eye eyedrop vials more easily and accurately.

The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...

Alcon’s Voyager is a fully automated, noncontact treatment approach that delivers 120 laser pulses through the limbus of the ...

New tariffs threaten the optical industry, prompting urgent reevaluation of sourcing strategies and pricing as deadlines ...

Krystal Biotech announced the first patient has been dosed in EMERALD-1, its phase 1/2 clinical trial evaluating KB801 for the treatment of neurotrophic keratitis (NK), a degenerative corneal disease ...

A Chinese study reveals that secondhand smoke exposure significantly increases the risk of early-onset myopia in children ...